SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IMNR - Immune Response

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mark B. Martell, CCM who wrote (72)4/30/1997 4:55:00 PM
From: Mark B. Martell, CCM   of 1510
 
Well,

I got an answer from Deborah Altman today from IMNR's investor relations
department. According to Deborah, there was an analyst call on Friday
at 2:30PM. The call was just to summarize the last four press releases
for the investment community. Further, there was no press release because
nothing new was said.

Remune is still on course, with data due back this fall, and commercialization
sometime during late 1998. In other words, nothing.

Others I have talked to inform me that this isn't the true story. That there
is more to be said regarding this conference call. My sources almost went as far
as to say that Investor Relations isn't fully disclosing the truth. What we need,
therefore, is some confirmation from a third party as to what was said during
the conference call. My guess is that something is going on here. I can't believe
that the insiders would pour more money into this animal, taking on personal debt,
to save it without some reward ....

Mark
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext